Niagen Bioscience, Inc. (NAGE)vsPepsiCo Inc (PEP)
NAGE
Niagen Bioscience, Inc.
$3.04
+0.16%
CONSUMER DEFENSIVE · Cap: $240.15M
PEP
PepsiCo Inc
$136.32
-0.24%
CONSUMER DEFENSIVE · Cap: $186.21B
Smart Verdict
WallStSmart Research — data-driven comparison
PepsiCo Inc generates 74970% more annual revenue ($96.90B vs $129.08M). NAGE leads profitability with a 12.4% profit margin vs 10.8%. NAGE trades at a lower P/E of 16.0x. PEP earns a higher WallStSmart Score of 71/100 (B).
NAGE
Hold40
out of 100
Grade: D
PEP
Strong Buy71
out of 100
Grade: B
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for NAGE.
Margin of Safety
+2.6%
Fair Value
$139.91
Current Price
$136.32
$3.59 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Every $100 of equity generates 23 in profit
Attractively priced relative to earnings
Reasonable price relative to book value
Every $100 of equity generates 47 in profit
Earnings expanding 137.0% YoY
Large-cap with strong market position
Attractively priced relative to earnings
Generating 1.5B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 2.4%
Revenue declined 4.3%
Earnings declined 75.0%
Trading at 8.4x book value
Weak financial health signals
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : NAGE
The strongest argument for NAGE centers on Debt/Equity, Return on Equity, P/E Ratio.
Bull Case : PEP
The strongest argument for PEP centers on Return on Equity, EPS Growth, Market Cap. PEG of 1.40 suggests the stock is reasonably priced for its growth.
Bear Case : NAGE
The primary concerns for NAGE are Market Cap, Operating Margin, Revenue Growth.
Bear Case : PEP
The primary concerns for PEP are Price/Book, Piotroski F-Score, Debt/Equity. Debt-to-equity of 2.41 is elevated, increasing financial risk.
Key Dynamics to Monitor
NAGE profiles as a declining stock while PEP is a value play — different risk/reward profiles.
NAGE carries more volatility with a beta of 2.09 — expect wider price swings.
PEP is growing revenue faster at 6.4% — sustainability is the question.
PEP generates stronger free cash flow (1.5B), providing more financial flexibility.
Bottom Line
PEP scores higher overall (71/100 vs 40/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Niagen Bioscience, Inc.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
PepsiCo Inc
CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA
PepsiCo, Inc. is an American based multinational food, snack, and beverage corporation headquartered in Harrison, New York, in the hamlet of Purchase. PepsiCo's business encompasses all aspects of the food and beverage market. It oversees the manufacturing, distribution, and marketing of its products.
Compare with Other PACKAGED FOODS Stocks
Want to dig deeper into these stocks?